Bumper Offer - Urjas oil Just @ Rs. 1
Romilast is a prescription medicine that is available as a Tablet, Granules. It is primarily used for the treatment of Asthma, Allergic Rhinitis. Romilast also has some secondary and off-label uses. These are listed below.
The optimal dosage of Romilast is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Romilast have been listed ahead. These side effects of Romilast are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Romilast has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Romilast related warnings talks about Romilast's effects on the liver, heart and kidney.
Other conditions have been mentioned below in the Romilast contraindications section.
Besides this, Romilast may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Romilast, it is important to know that it is safe while driving, and is habit-forming.
Romilast is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Romilast is used -
Severe
Moderate
Mild
Is the use of Romilast safe for pregnant women?
Romilast may have some side effects during pregnancy. Pregnant women should discontinue the use of Romilast, and talk to their doctor, if they notice any discomfort.
Is the use of Romilast safe during breastfeeding?
Romilast can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Romilast on the Kidneys?
Romilast has very mild side effects on the kidneys.
What is the effect of Romilast on the Liver?
There may be an adverse effect on the liver after taking Romilast. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Romilast on the Heart?
Romilast has very mild side effects on the heart.
Romilast should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Romilast unless your doctor advises you to do so -
Is this Romilast habit forming or addictive?
Romilast is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Romilast does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Romilast should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Romilast for mental disorders.
Interaction between Food and Romilast
Due to the absence of research, it is difficult to say how Romilast and food will interact.
Interaction between Alcohol and Romilast
Consuming Romilast with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)